Recent studies carried out in this laboratory have demonstrated possible involvement of serotonin in regulation of carbohydrate metabolism in rats Ui et al., 1960a, b; Warashina et al., 1960; Miyawaki et al., 1961) . It was observed that intravenous injection of serotonin caused a glycogenolysis in both liver and muscle , whereas administration through subcutaneous route resulted in an increase in glycogen level of diaphragm . Furthermore, glycogenetic effect of insulin was accelerated by serotonin treatment . Glycogenolytic effect of serotonin was quite recently observed in vitro either in diaphragms incubated with fairly large amount of this agent(Ui and Kobayashi, 1962) or in liver slices (Ui et al., 1962) , though glycogenolysis induced in vivo may be partly accounted for by anoxemia or tissue anoxia (Page, 1958) as well as secretion of epinephrine (Hagen, 1957; Kobayashi et al., 1960a; Ui et al., 1960a; Columbo et al., 1960; Ui, 1962) caused by large dose of serotonin. On the other hand, an increase in muscle glycogen after subcutaneous injection of serotonin seemed to be of much interest as well, for few glycogenetic endocrine factor other than insulin has been disclosed so far.
Thus, glycogenetic activity of serotonin was further examined and this paper deals with the experiments performed to get in vitro effect of serotonin in isolated rat diaphragm. After incubation an aliquot was withdrawn to determine glucose and lactate, then the tissue was blotted, weighed and dropped into 0.5ml of 30% KOH. The analysis of glycogen in tissue was carried out according to the procedure reported previously ). Glucose and lactate determination was done according to Somogyi-Nelson (Somogyi, 1945; Nelson, 1944) and Barker-Summerson (Barker and Summerson, 1941) respectively.
METHODS
Test of significance was applied, in all cases, to mean differences between treated tissue and control tissue from paired incubation.
Serotonin used was a commercial preparation from Nutritional Biochemicals Corporation and dosage was expressed as weight of complex with creatinine sulfate.
Glucagon were noted in the case of diabetic tissues (Table 7) . Table 8 Tables 9 and 10 , glycogen formation is very active during incubation in spite of the high initial level of glycogen as well as depressed glucose uptake. Inasmuch as glycogen synthesis is assumed to proceed in such tissue preparations to a considerable degree using the intermediaries as starting materials, insulin effect on glycogen formation is observed irrespective of occurrence of inhibition of glucose uptake. On the other hand, since medium glucose need not be'pulled' into cells by stimulated glycogenesis in glucose-fed tissue, inhibitory effect of serotonin on glucose utilization may be presented. The muscle tissue of glucose-fed rats is considered to be bound with fairly large amount of endogenous insulin which in all likelihood is the cause of plenty content of intermediaries.
Comparison' of the glycogen synthesis between normal and diabetic diaphragm revealed that the amount of glycogen synthesized during in vitro incubation of muscle was larger in diabetic than in normal. The value obtained with diabetic was about twice the normal. The level of glycogen which attained after incubation, not the amount of net synthesis during incubation, was also higher in diabetic than in normal diaphragm as evidenced in the control value of glycogen in experiments 1 and 2 in Table 4 and significance level of the difference for all the data thus far obtained is below 0.01. Similar relationship was found in the data presented by the other investigators (Clark and Forbath, 1960) in bicarbonatebuffered medium.
Since currently available evidence shows that inhibitory factor on peripheral glucose utilization, possibly of pituitary origin, is predominant in diabetic organism deprived of endogenous insulin, the following explanation could be given as to the mechanism involved in responsiveness of diabetic tissue to serotonin with respect to inhibitory effect on glucose utilization; that is, suppressive action of serotonin on glucose utilization manifests itself through the mediation of this inhibitory factor. Alternative explanation will be presented from similarity of diabetic diaphragm to glucose-fed non-diabetic tissue in pronounced operation of glycogenetic pathway. If diabetic tissues were provided with intermediaries readily convertible to glycogen as a result of any block in other pathway (s), inhibitory effect of serotonin on glucose utilization may be accounted for on the same basis in glucose-fed diaphragm.
In vitro findings presented here seems consistent with the results obtained by in vivo experiments previously reported.
Subcutaneous injection of serotonin resulted in glycogenesis in diaphragm , whereas hypoglycemia caused by serotonin through this route was not so pronounced suggesting lack of increase in peripheral glucose uptake. It should be noted that increment of glycogenetic action of insulin by serotonin treatment was observed in glucose-fed animals . Inhibitory action of serotonin on glucose utilization by muscle tissues will be further discussed in the subsequent publication (Ui and Kobayashi, 1962) 
